TRYNGOLZA
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TRYNGOLZA, covering 2024-12-19 to 2025-12-03. Get the full timeline:
Most recent: EMA Authorised: Tryngolza (olezarsen sodium) — Swedish Orphan Biovitrum AB (publ)